Skip to main content

Table 1 Baselines characteristics

From: CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors

 

N = 263

Age (years) (±SD)

26.4 (8.9)

Seminoma

164 (62%)

Non-Seminoma or mixed GCT

99 (38%)

Clinical Stage (AJCC)

 -Stadium I

190 (72%)

 -Stadium IS

4 (2%)

 -Stadium II

35 (13%)

 -Stadium III

34 (13%)

IGCCCG risk groups

 -Good risk

56 (21%)

 -Intermediate risk

13 (5%)

 -Poor risk

4 (2%)

  1. AJCC American Joint Committee on Cancer, BMI Body-Mass-Index (kg/cm2), IGCCCG International Germ Cell Cancer Collaborative Group, IQR Interquartile Range, SD Standard deviation, TNM tumor, nodes and metastases system of cancer staging
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us